Tony S.K. Mok, BMSc, MD, FRCPC | Authors

Articles

The Utility of Afatinib in Lung Cancer

November 05, 2013

Tony S.K. Mok, BMSc, MD, FRCPC, professor, Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong, China, discusses the utility of afatinib in patients with lung cancer.

Plasma Testing Approaches for Lung Cancer

October 07, 2013

Tony S.K. Mok, BMSc, MD, FRCPC, professor, Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong, China, discusses different plasma testing approaches for patients with lung cancer.